Mutations in the IDH1 and IDH2 genes strongly correlate with the development of glioma, acute myeloid leukemia, chondrosarcoma, intrahepatic cholangiocarcinoma, and angioimmunoblastic carcinomas of T-cell lymphomas [52]. Here, IDH1 is linked to intrahepatic cholangiocarcinoma.